CORDIS
EU research results

CORDIS

English EN
European Initiative for Basic Research in Microbiology and Infectious Diseases

European Initiative for Basic Research in Microbiology and Infectious Diseases

Objective

By initially building a strong coalition among five European centres of excellence, the objectives of EIMID are to reach a critical mass on relevant microbiology topics; to allow rapid and effective scientific reaction to emerging problems; to foster exchange of scientists; to improve the visibility of Microbiology and Infectious Diseases as a discipline of key importance in Europe; to attract the best fellows and post-docs to the area; to counter the current brain drain of young European investigators to USA.

In this context, a consortium will come together, composed of the small Italian company ALTA, the Max Planck Institute for Infection Biology in Berlin, the Centre for Molecular Microbiology and Infection at Imperial College London, the Institut Pasteur in Paris, the Karolinska Institutet in Stockholm, and the vaccine company Chiron in Siena. The consortium will organise a 3-year PhD training programme for fellows who will visit different EIMID centres. Interdisciplinarity and academic-industrial cooperation will be emphasized. Ten fellows will follow an individual training pathway in the areas of host-pathogen interaction and novel strategies for designing vaccines and inhibitors. Parallel training aimed at improving complementary skills will implement the fellows' future role in the global scientific world.

Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE S.R.L.

Address

Via Nino Bixio 15
Siena

Italy

Administrative Contact

Aldo TAGLIABUE (Dr)

Participants (6)

Sort alphabetically

Expand all

MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.

Germany

IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

United Kingdom

INSTITUT PASTEUR

France

KAROLINSKA INSTITUTET

Sweden

CHIRON S.R.L.

Italy

NOVARTIS VACCINES AND DIAGNOSTICS SRL

Italy

Project information

Grant agreement ID: 20311

  • Start date

    1 March 2006

  • End date

    28 February 2010

Funded under:

FP6-MOBILITY

Coordinated by:

ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE S.R.L.

Italy